thus , the equal activity of native igf-i and its recombinant dna-produced analogs coupled with the higher potency of igf-i ( compared to igf-ii ) suggest that the type ii receptor plays little or no role in the four actions of the somatomedins studied in l6 myoblasts .
C0021666
igf-ii
C0037657
somatomedins